Jill Hall1, K Julia Kaal2,3, Junho Lee2, Ross Duncan2, Nicole Tsao2, Mark Harrison2,4,5. 1. Faculty of Pharmacy and Pharmaceutical Sciences, 3-236 Edmonton Clinic Health Academy, University of Alberta, 11405-87 Ave NW, Edmonton, AB, T6G 1C9, Canada. jill.hall@ualberta.ca. 2. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. 3. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. 4. Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, BC, Canada. 5. Arthritis Research Canada, Richmond, BC, Canada.
Abstract
PURPOSE OF THE REVIEW: A number of novel models of care utilizing allied healthcare professionals, including nurses and pharmacists, have emerged as an alternate to rheumatologist specialist care to achieve disease outcomes in patients with inflammatory arthritis. We conducted a review of the literature for studies from the past 5 years that reported on measures of patient satisfaction and/or any health economic outcome in a model of care where the care providers had substantial, but not completely independent, responsibility. RECENT FINDINGS: Previous reviews have summarized the available evidence for collaborative models of care led by nurses (only), which demonstrate that patients with inflammatory arthritis achieve similar disease outcomes and feel well supported with their person-centered care. Patients are generally highly satisfied with the care provided in collaborative care models, in line with if not greater than that provided by rheumatologists. However, we identified substantial variability in direct costs and/or overall intervention costs and measures of health-related quality of life across the various countries and healthcare systems. Overall, nursing-led interventions likely cost more than do physician-led models of care in the short-term but may lead to greater quality of life, as demonstrated with a disease-specific measure.
PURPOSE OF THE REVIEW: A number of novel models of care utilizing allied healthcare professionals, including nurses and pharmacists, have emerged as an alternate to rheumatologist specialist care to achieve disease outcomes in patients with inflammatory arthritis. We conducted a review of the literature for studies from the past 5 years that reported on measures of patient satisfaction and/or any health economic outcome in a model of care where the care providers had substantial, but not completely independent, responsibility. RECENT FINDINGS: Previous reviews have summarized the available evidence for collaborative models of care led by nurses (only), which demonstrate that patients with inflammatory arthritis achieve similar disease outcomes and feel well supported with their person-centered care. Patients are generally highly satisfied with the care provided in collaborative care models, in line with if not greater than that provided by rheumatologists. However, we identified substantial variability in direct costs and/or overall intervention costs and measures of health-related quality of life across the various countries and healthcare systems. Overall, nursing-led interventions likely cost more than do physician-led models of care in the short-term but may lead to greater quality of life, as demonstrated with a disease-specific measure.
Entities:
Keywords:
Costs; Health economics; Inflammatory arthritis; Model of care; Multidisciplinary care; Patient satisfaction
Authors: Santiago Muñoz Fernández; Pablo Lázaro y De Mercado; Javier Alegre López; Raquel Almodóvar González; Alberto Alonso Ruiz; Francisco Javier Ballina García; Ana María Bilbao Cantarero; Mercedes Cabañas Sáenz; Rosario García-Vicuña; Mauricio Mínguez Vega; Isabel Padró Blanch; José Andrés Román Ivorra; Encarnación Roncal Marqueta Journal: Reumatol Clin Date: 2013-05-18
Authors: Yvonne van Eijk-Hustings; Astrid van Tubergen; Carina Boström; Elena Braychenko; Beate Buss; José Felix; Jill Firth; Alison Hammond; Benny Harston; Cristina Hernandez; Masa Huzjak; Jana Korandová; Marja Leena Kukkurainen; Robert Landewé; Maryse Mezieres; Marijana Milincovic; Antonella Moretti; Susan Oliver; Jette Primdahl; Marieke Scholte-Voshaar; Jenny de la Torre-Aboki; Jennifer Waite-Jones; Rene Westhovens; Heidi Andersen Zangi; Turid Heiberg; Jackie Hill Journal: Ann Rheum Dis Date: 2011-10-28 Impact factor: 19.103
Authors: Ross Duncan; Lucy Cheng; Michael R Law; Kam Shojania; Mary A De Vera; Mark Harrison Journal: BMC Health Serv Res Date: 2022-03-11 Impact factor: 2.655